Log In
BCIQ
Print this Print this
 

Erythropoietin (EPO) receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Erythropoietin (EPO) receptor

BCIQ
Print ChartPrint this
0 1 1 0 0 2 2 0 1 13 0 0 1 0 0 0 0 0 1 0
Phases of DevelopmentPreclinicalPhase IPhase IIPhase IIIMarketed
Cancer

0

0

0

1

0

Cardiovascular

0

0

1

0

0

Hematology

2

2

0

1

13

Neurology

0

1

1

0

0




 Products Targeting Erythropoietin (EPO) receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$2,646.8M

$1,824.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today